Research Progress on Neuroprotective Effects of Isoquinoline Alkaloids
Molecules · 16.06.2023 · 28 (12) · 4797
DOI: 10.3390/molecules28124797 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 16.06.2023. Verfasst von Jinhua Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Medical College, Hangzhou 310013, China. Hauptthemen laut MEDLINE: Neuroprotective Agents, Alkaloids, Neurodegenerative Diseases, Parkinson Disease. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, Medical and health Science and Technology Project of Zhejiang Province, Natural Science Foundation of Zhejiang province.
Abstract (Originalsprache)
Neuronal injury and apoptosis are important causes of the occurrence and development of many neurodegenerative diseases, such as cerebral ischemia, Alzheimer’s disease, and Parkinson’s disease. Although the detailed mechanism of some diseases is unknown, the loss of neurons in the brain is still the main pathological feature. By exerting the neuroprotective effects of drugs, it is of great significance to alleviate the symptoms and improve the prognosis of these diseases. Isoquinoline alkaloids are important active ingredients in many traditional Chinese medicines. These substances have a wide range of pharmacological effects and significant activity. Although some studies have suggested that isoquinoline alkaloids may have pharmacological activities for treating neurodegenerative diseases, there is currently a lack of a comprehensive summary regarding their mechanisms and characteristics in neuroprotection. This paper provides a comprehensive review of the active components found in isoquinoline alkaloids that have neuroprotective effects. It thoroughly explains the various mechanisms behind the neuroprotective effects of isoquinoline alkaloids and summarizes their common characteristics. This information can serve as a reference for further research on the neuroprotective effects of isoquinoline alkaloids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Hangzhou Medical College, Hangzhou 310013, China.
- Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province, Hangzhou 310013, China.
ORCID-Profile: Benhan Xiang
Förderung
- Key Laboratory of Neuropsychiatric Drug Research of Zhejiang Province
- Medical and health Science and Technology Project of Zhejiang Province
- Natural Science Foundation of Zhejiang province
- Zhejiang Province Health High-level Talent Training Project
Zitieren
APA
Li, J., Wu, Y., Dong, S., Yu, Y., Wu, Y., Xiang, B., & Li, Q. (2023). Research Progress on Neuroprotective Effects of Isoquinoline Alkaloids. Molecules, 28(12), 4797. https://doi.org/10.3390/molecules28124797
Vancouver
Li J, Wu Y, Dong S, Yu Y, Wu Y, Xiang B, et al. Research Progress on Neuroprotective Effects of Isoquinoline Alkaloids. Molecules. 2023;28(12):4797. doi:10.3390/molecules28124797
BibTeX
@article{Li2023,
author = {Li, Jinhua and Wu, Yarong and Dong, Shuze and Yu, Ye and Wu, Yuhao and Xiang, Benhan and Li, Qin},
title = {Research Progress on Neuroprotective Effects of Isoquinoline Alkaloids},
journal = {Molecules},
year = {2023},
volume = {28},
number = {12},
pages = {4797},
doi = {10.3390/molecules28124797}
}
EUVIMED